CYP1A2 Genetic Polymorphisms are Associated with Early Antidepressant Escitalopram Metabolism and Adverse Reactions

• Chien IC , KuoCC, BihSH et al. The prevalence and incidence of treated major depressive disorder among National Health Insurance enrollees in Taiwan, 1996 to 2003. Can. J. Psychiatry 52(1) , 28–36 (2007).
   PubMed Web of Science ®Google Scholar
• Angst J , GammaA, EndrassJRM et al. Is the association of alcohol use disorders with major depressive disorder a consequence of undiagnosed bipolar-II disorder? Eur. Arch. Psychiatry Clin. Neurosci. 256(7) , 452–457 (2006).
   PubMed Web of Science ®Google Scholar
• Rao N . The clinical pharmacokinetics of escitalopram. Clin. Pharmacokinet.46(4) , 281–290 (2007).
   PubMed Web of Science ®Google Scholar
• Burke WJ . Escitalopram. Expert Opin. Investig. Drugs11(10) , 1477–1486 (2002).
   PubMed Web of Science ®Google Scholar
• Von Moltke L , GreenblattD, GiancarloG, GrandaB, HarmatzJ, ShaderR. Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram. Drug Metab. Dispos.29(8) , 1102–1109 (2001).
   PubMed Web of Science ®Google Scholar
• Shimada T , YamazakiH, MimuraM, InuiY, GuengerichF. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther.270(1) , 414–423 (1994).
   PubMed Web of Science ®Google Scholar
• Palatini P , CeolottoG, RagazzoF et al. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J. Hypertens.27(8) , 1594–1601 (2009).
   PubMed Web of Science ®Google Scholar
• Laika B , LeuchtS, HeresS, SchneiderH, SteimerW. Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome. Pharmacogenomics J.10(1) , 20–29 (2010).
   PubMed Web of Science ®Google Scholar
• Zhang WV , D‘EspositoF, EdwardsRJ, RamzanI, MurrayM. Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes. Drug Metab. Dispos.36(12) , 2547–2555 (2008).
   PubMed Web of Science ®Google Scholar
• Liu H , HuY, LiuY, HeY, LiW, YangL. CYP1A2 is the major isoform responsible for paeonol O-demethylation in human liver microsomes. Xenobiotica39(9) , 672–679 (2009).
   PubMed Web of Science ®Google Scholar
• Gunes A , OzbeyG, Vural Eh et al. Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population. Pharmacogenomics10(5) , 769–778 (2009).
   PubMed Web of Science ®Google Scholar
• Ghahramani P , EllisS, LennardM, RamsayL, TuckerG. Cytochromes P450 mediating the N-demethylation of amitriptyline. Br. J. Clin. Pharmacol.43(2) , 137–144 (1997).
   PubMed Web of Science ®Google Scholar
• Nielsen K , FlinoisJ, BeauneP, BrosenK. The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways. J. Pharmacol. Exp. Ther.277(3) , 1659–1664 (1996).
   PubMed Web of Science ®Google Scholar
• Spina E , PollicinoA, AvenosoA, CampoG, PeruccaE, CaputiA. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects. Ther. Drug Monit.15(3) , 243–246 (1993).
   PubMed Web of Science ®Google Scholar
• Skinner M , KuanHY, PanA et al. Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers. Clin. Pharmacol. Ther. 73(3) , 170–177 (2003).
   PubMed Web of Science ®Google Scholar
• Stormer E , Von Moltke LL, Shader RI, Greenblatt DJ. Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4. Drug Metab. Dispos.28(10) , 1168–1175 (2000).
   PubMed Web of Science ®Google Scholar
• Dorado P , BereczR, Penas-LledoEM, De La Rubia A, Llerena A. No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients. Eur. J. Clin. Pharmacol.63(5) , 527–528 (2007).
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (4th Edition, Text Revision). American Psychiatric Association, Washington, DC, USA (2000).
   Google Scholar
• Hamilton M . Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol.6(4) , 278–296 (1967).
   PubMedGoogle Scholar
• Hamilton M . A rating scale for depression. J. Neurol. Neurosurg. Psychiatry23 , 56–62 (1960).
   PubMed Web of Science ®Google Scholar
• Guy W . ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville, MD, USA (1976).
   Google Scholar
• Riedel M , MollerH, ObermeierM et al. Response and remission criteria in major depression – a validation of current practice. J. Psychiatr. Res. 44(15) , 1063–1068 (2010).
   PubMed Web of Science ®Google Scholar
• McGahuey C , GelembergA, LaukesC et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J. Sex Marital Ther. 26 , 25–40 (2000).
   PubMed Web of Science ®Google Scholar
• Kristoffersen L , BuggeA, LundanesE, SlordalL. Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection. J. Chromatogr. B. Biomed. Sci. App.734(2) , 229–246 (1999).
   PubMed Web of Science ®Google Scholar
• Tsai MH , LinKM, HsiaoMC et al. Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response. Pharmacogenomics 11(4) , 537–546 (2010).
   PubMed Web of Science ®Google Scholar
• Liang KY , ZegerSL. Longitudinal data analysis using generalized linear models. Biometrika73(1) , 13–22 (1986).
   Web of Science ®Google Scholar
• Barrett J , FryB, MallerJ, DalyM. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics21(2) , 263–265 (2005).
   PubMed Web of Science ®Google Scholar
• Schaid DJ , RowlandCM, TinesDE, JacobsonRM, PolandGA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet.70(2) , 425–434 (2002).
   PubMed Web of Science ®Google Scholar
• Jia Y , YuX, ZhangB et al. No association between polymorphisms in three genes of cytochrome p450 family and paranoid schizophrenia in northern Chinese Han population. Eur. Psychiatry 19(6) , 374–376 (2004).
   PubMed Web of Science ®Google Scholar
• Sun P , QianJ, ZhangZB et al. Polymorphisms in phase I and phase II metabolism genes and risk of chronic benzene poisoning in a Chinese occupational population. Carcinogenesis 29(12) , 2325–2329 (2008).
   PubMed Web of Science ®Google Scholar
• Yuan HY , ChiouJJ, TsengWH et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res. 34(Web Server issue) , W635–W641 (2006).
   PubMed Web of Science ®Google Scholar
• Gabriel SB , SchaffnerSF, NguyenH et al. The structure of haplotype blocks in the human genome. Science 296(5576) , 2225–2229 (2002).
   PubMed Web of Science ®Google Scholar
• Schrenk D , BrockmeierD, MorikeK, BockK, EichelbaumM. A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers. Eur. J. Clin. Pharmacol.53(5) , 361–367 (1998).
   PubMed Web of Science ®Google Scholar
• Sachse C , BrockmollerJ, BauerS, RootsI. Functional significance of a C→ A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br. J. Clin. Pharmacol.47(4) , 445–449 (1999).
   PubMed Web of Science ®Google Scholar
• Chen X , WangL, ZhiL et al. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population. Clin. Pharmacol. Ther. 78(3) , 249–259 (2005).
   PubMed Web of Science ®Google Scholar
• Zhou SF , YangLP, ZhouZW, LiuYH, ChanE. Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2. AAPS J.11(3) , 481–494 (2009).
   PubMed Web of Science ®Google Scholar
• Zhou SF , WangB, YangLP, LiuJP. Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab. Rev.42(2) , 268–354 (2009).
   Web of Science ®Google Scholar
• Takeuchi DT , ChungRC, LinKM et al. Lifetime and twelve-month prevalence rates of major depressive episodes and dysthymia among Chinese Americans in Los Angeles. Am. J. Psychiatry 155(10) , 1407–1414 (1998).
   PubMed Web of Science ®Google Scholar

▪ Websites

• National Institutes of Health Clinical Trial. www.clinicaltrial.gov/ct/show/NCT00384020
   Google Scholar
• HapMap. http://hapmap.ncbi.nlm.nih.gov/index.html.en
   Google Scholar
• Transcription Element Search System. www.cbil.upenn.edu/cgi-bin/tess/tess33?RQ=SEA-FR-Query
   Google Scholar